New Tests Launched in October

By Emily Linginfelter • November 7, 2019

Share this:

In October 2019, Mayo Clinic Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Seven new tests were launched in October 2019 by Mayo Clinic Laboratories:

• Antithrombin Deficiency, SERPINC1Gene, Next-Generation Sequencing, Varies (Mayo ID: ATNGS)
• Chromogenic Factor VIII Inhibitor Bethesda Titer, Plasma (Mayo ID: CH8B)
• CryptococcusAntigen Screen, Lateral Flow Assay, Urine (Mayo ID: ULFA)
• CryptococcusAntigen Titer, Lateral Flow Assay, Urine (Mayo ID: ULFAT)
• Francisella tularensisAntibody, IgM and IgG, ELISA, Serum (Mayo ID: TULAB)
• Hemophilia B, F9Gene, Next-Generation Sequencing, Varies (Mayo ID: NGSF9)
• Protein C Deficiency, PROCGene, Next-Generation Sequencing, Varies (Mayo ID: PCNGS)

In addition to these new tests, the department also announced several test changes. Click the links below to view test changes announced by Mayo Clinic Laboratories:

• All New Tests
• Test Changes
• Test Status Updates
• View All Updates

Emily Linginfelter

Emily Linginfelter is a Marketing Associate at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Emily has worked at Mayo Clinic since 2018.